Abstract:Earlier this year, the first death in the United States involving a pan-resistant Klebsiella pneumonia was reported in a patient in whom sepsis developed from a surgical site infection [1]. This case highlights the growing importance of antibiotic resistance to surgeons and their patients. In support of the 2017 U.S. Antibiotic Awareness Week [2], members and officers of the Surgical Infection Society (SIS) are championing the proper usage of antibiotic agents and partnering with the centers for Disease Control and Prevention (CDC), the Global Alliance for Infections in Surgery, and the World Society of Emergency Surgery in attempting to elevate each surgeon’s commitment to proper and effective antibiotic stewardship globally. Tools and resources to support this endeavor are available this week on the Society’s web site (www.sisna.org). In this issue of Surgical Infections, Dr. Massimo Sartelli and over 230 experts from 83 different countries provide a global declaration on appropriate use of antimicrobial agents in hospitals worldwide. Within this declaration, the authors succinctly highlight the contribution of antibiotic exposure, misuse, and overuse to antibiotic resistance and outline the fundamental principles of appropriate antibiotic prophylaxis and therapy in surgery. The Surgical Infection Society endorses this document that has been translated into several languages and made available online with the article as open access for all to view (see online supplementary material at www.liebertpub.com/sur). Global action is needed urgently to slow the trend of increasing antibiotic resistance. Proper education of healthcare providers and the general public is needed in addition to the adoption of broader multi-disciplinary stewardship programs to achieve appropriate antimicrobial use. Although antibiotic agents are used for numerous indications beyond those that are surgical, surgeons should not abdicate their responsibility to ensure proper antibiotic use and appropriate stewardship for their patients. Surgeons are best positioned to ensure that their patients receive timely and appropriate antibiotic therapy at the correct dosage with the shortest indicated course and narrowest spectrum [3]. While inter-disciplinary teams can enhance the performance of stewardship programs [4–8], inter-disciplinary involvement should not diffuse the surgeon’s responsibility for the patient’s outcome. Performance issues remain common on both sides of the antibiotic prescribing equation; inadequate spectrum, delayed initiation, and insufficient dosing regimens on one side and excessive length of prophylaxis and therapeutic courses, inappropriately broad therapy, and antibiotic use when not indicated on the other. Surgeons must understand the impact of poor antibiotic practices in their patients, both in terms of an inadequate response to therapy for an existing infection and an increased risk of subsequent infectious complications, particularly antibiotic resistant infections. The surgical community has been slow to respond [3,9,10]. On a daily basis, poor compliance on both sides of the antibiotic prescribing equation is common, although frequently unrecognized and undocumented. Restricting the use of these drugs to specialists who are not involved primarily in the patient’s care is a drastic solution that will likely have unintended consequences and can be avoided by education and the adoption of appropriate stewardship. That the Joint Commission on Accreditation of Health Care Organizations is now involved actively, mandating demonstration of education of antimicrobial stewardship by hospitals during their accreditation visits, should not be a surprise. Through the 2017 U.S. Antibiotic Awareness Week (formerly the ‘‘Get Smart About Antibiotics Week’’), the CDC is raising awareness of antibiotic resistance as a serious public health concern that requires action [2]. In their global declaration in this issue, Sartelli et al. have highlighted the extent and implications of antimicrobial resistance, a problem that is compounded by a lack of effective drugs coming down the pipeline. This combination has required that old drugs with suboptimal safety profiles are now administered in combination to fight resistant organisms. The authors also highlight the multi-disciplinary approach that is likely required to maximize stewardship performance and summarize the basic

Design of electronic programmable board with user-friendly touch screen interface for management and control of thermosolar plant parameters

Effects of a Probiotic, Enterococcus Faecium, on Growth Performance, Intestinal Morphology, Immune Response, and Cecal Microflora in Broiler Chickens Challenged with Escherichia Coli K88

Cell free preparations of probiotics exerted antibacterial and antibiofilm activities against multidrug resistant E. coli

AIT-082, a novel purine derivative with neuroregenerative properties.

Effects of cell-free supernatant of Lactobacillus acidophilus LA5 and Lactobacillus casei 431 against planktonic form and biofilm of Staphylococcus aureus

Lactic acid bacteria biofilms and their ability to mitigate Escherichia coli O157:H7 surface colonization

Use of Potential Probiotic Lactic Acid Bacteria (LAB) Biofilms for the Control of Listeria monocytogenes, Salmonella Typhimurium, and Escherichia coli O157:H7 Biofilms Formation

Characterization of anti-Listeria bacteriocins isolated from shellfish: potential antimicrobials to control non-fermented seafood

Antimicrobial activity, antibiotic susceptibility and virulence factors of Lactic Acid Bacteria of aquatic origin intended for use as probiotics in aquaculture

INHIBITORY EFFECT OF DIFFERENT PROBIOTIC FORMULATIONS ON SALMONELLA HEIDELBERG, AVIAN PATHOGENIC ESCHERICHIA COLI AND CAMPYLOBACTER JEJUNI

Potential of cell-free supernatants from cultures of selected lactic acid bacteria and yeast obtained from local fermented foods as inhibitors of Listeria monocytogenes, Salmonella spp. and Staphylococcus aureus

Performance Bounds of Algorithms for Scheduling Advertisements on a Web Page

Probiotic cell-free supernatant as effective antimicrobials against Klebsiella pneumoniae and reduce antibiotic resistance development

Bacterial adhesion inhibition by microalgal EPSs from Cylindrotheca closterium and Tetraselmis suecica biofilms

In Vitro Antagonistic Effect of Lactic Acid Bacteria Isolated from Fermented Beverage and Finfish on Pathogenic and Foodborne Pathogenic Microorganism in Ethiopia

The impacts of antimicrobial and antifungal activity of cell-free supernatants from lactic acid bacteria in vitro and foods

Exploiting Lactoferricin (17-30) as a Potential Antimicrobial and Antibiofilm Candidate Against Multi-Drug-Resistant Enteroaggregative Escherichia coli

Inhibitory Effect of Substances Produced by Native Lactococcus lactis Strains of Tropical Fruits towards Food Pathogens

Development of Desiccation-Tolerant Probiotic Biofilms Inhibitory for Growth of Foodborne Pathogens on Stainless Steel Surfaces

In Vitro Preformed Biofilms of Bacillus safensis Inhibit the Adhesion and Subsequent Development of Listeria monocytogenes on Stainless-Steel Surfaces

Surgical Infection Society: We Endorse Antimicrobial Stewardship We Stand by Our International Colleagues and Societies in the Fight for Proper Antimicrobial Therapy.